Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in RAPP — Rapport Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,170,086
-$297,659 QoQ
Shares Held
76,076
-31.4% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 159 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. RAPP ranks #169 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in RAPP

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,170,086 76,076
2026-03-31 $3,467,745 110,826
2025-12-31 $1,048,337 34,553
2025-09-30 $1,724,411 58,061
2025-06-30 $137,883 12,127
2025-03-31 $74,833 7,461
2024-12-31 $116,692 6,578
2024-09-30 $391,372 19,110